Request Trial
JFontan / Shutterstock.com
18 August 2026NewsMedTechMarisa Woutersen

Abbott fends off Chinese rival’s patent challenge at UPC

The European court has backed Abbott in a dispute over glucose-monitoring technology, while offering guidance on a key added-matter issue.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

MedTech
Fed Circ refuses to rehear Insulet’s $59.4m trade secret loss
20 October 2026   A panel rejected the Omnipod maker’s request for a rehearing in its trade secrets dispute with South Korean insulin pump maker EOFlow, leaving in place a ruling that overturned a $59.4 million damages award and raising questions over the three-year statute of limitations under the DTSA.
MedTech
Align Technology notches another win in escalating clear aligner feud
19 October 2026   The US clear aligner giant has dealt another blow to a Chinese rival, securing an infringement ruling at the UPC as the pair wage a growing patent dispute across Europe, the US and China.
MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026   The two major medical device makers are clashing over Atraverse’s Hotwire system, with Boston Scientific claiming the product infringes its patented radiofrequency transseptal-access technology, used in heart surgery.


Editor's picks

Boston Scientific expands dispute with J&J unit over cardiac-access technology
MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026

Editor's picks

MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026
In-house counsel
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
1 October 2026
Pharma
Lilly loses Fed Circ rehearing bid, sparking enablement questions
1 October 2026
Pharma
Takeda sees off UK challenge to Elvanse SPC
28 September 2026
Pharma
Behind the case: How Novartis defended its blockbuster Entresto in the UK
22 September 2026
Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026

More features

Fed Circ refuses to rehear Insulet’s $59.4m trade secret loss
Boehringer accuses Dr Reddy’s of ‘weaponising’ plausibility
Align Technology notches another win in escalating clear aligner feud
Guardant loses second patent challenge to TwinStrand amid $245m damages fallout
Boehringer and Dr Reddy’s spar over plausibility as trial wraps up
Haynes Boone expands in California with new office
Accord’s generic hopes dashed in cyanide antidote ruling
Novo’s semaglutide protection weakens after European ruling